Lincoln National Corp Atossa Therapeutics, Inc. Transaction History
Lincoln National Corp
- $3.11 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding ATOS
# of Institutions
90Shares Held
29MCall Options Held
39.8KPut Options Held
90.9K-
Black Rock Inc. New York, NY9.2MShares$7.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$5.49 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.81MShares$2.34 Million0.0% of portfolio
-
State Street Corp Boston, MA1.76MShares$1.46 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.56MShares$1.29 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $105M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...